Gait deficit is a common and disabling symptom of MS. By supporting the brain’s ability to form new pathways, it may be able to compensate for the damage caused by MS. While this typically happens over a long period of time, the process of activating new and/or compensatory pathways in the brain can be promoted by utilizing neuromodulation techniques via a non-surgical device – this is where PoNS comes in.
The efficacy of PoNS Therapy has been assessed in 2 randomized clinical trials and 1 retrospective analysis involving patients with gait deficit due to mild to moderate symptoms from MS.
- The Tyler et al study suggests that individuals with MS using PoNS in conjunction with PT had improved gait scores over twice that of those using a sham device with PT.1
- The Leonard et al study suggests that PoNS stimulation can drive neuroplasticity to enhance gait motor performance.2
- A retrospective analysis of real-world treatment outcomes showed clinically and statistically significant improvements in functional gait assessment (FGA) with PoNS Therapy.3
To view the Real-World Evidence as presented at the 2022 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting, click here.